2-acylaminothiazole derivative or salt thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8765764
APP PUB NO 20130079351A1
SERIAL NO

13677520

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A 2-acylaminothiazole derivative or a pharmaceutically acceptable salt thereof having an excellent effect of proliferating human c-mpl-Ba/F3 cells and an activity of increasing platelets based on the effect of promoting the formation of megakaryocytic colonies. A compound or a pharmaceutically acceptable salt thereof useful in treating thrombocytopenia.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ASTELLAS PHARMA INC5-1 NIHONBASHI-HONCHO 2-CHOME CHUO-KU TOKYO 1038411 ?1038411

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hirayama, Fukushi Tokyo, JP 20 222
Koga, Yuji Tokyo, JP 185 2288
Nagata, Hiroshi Tokyo, JP 144 984
Sugasawa, Keizo Tokyo, JP 19 198
Suzuki, Ken-Ichi Tokyo, JP 28 273
Wakayama, Ryutaro Tokyo, JP 9 126
Watanuki, Susumu Tokyo, JP 13 171

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 1, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00